AstraZeneca to withdraw Imfinzi US indication for bladder cancer
February 22, 2021Sales and Marketing AstraZeneca, Imfinzi
AstraZeneca will voluntarily withdraw the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or …
Seagen’s breast cancer drug TUKYSA gets UK approval
February 22, 2021Sales and Marketing Cancer, MHRA, Seagen
The MHRA has granted marketing authorisation in the UK for Seagen’s TUKYSA (tucatinib) in combination with trastuzumab and capecitabine, for …
Pharmafile.com’s top 10 news stories of the week
February 19, 2021Medical Communications COVID-19, COVID-19 vaccine, Vaccine, pharma news, top 10, top news stories
In the last week, a number of COVID-19 new vaccine developments have been made. Pfizer and BioNTech’s vaccine has proven …
New Cell Guidance technology has potential to help treat cancer
February 19, 2021Medical Communications Cancer, cancer treatment, cell guidance systems, macrophages, pharma news
Cell Guidance Systems’ new POlyhedrin Delivery System (PODS) technology has been shown to have therapeutic potential in the treatment of …
Cascade Chemistry begins $14m manufacturing facility expansion
February 19, 2021Medical Communications Cascade Chemistry, manufacturing
Cascade Chemistry, a leading pharmaceutical contract development and manufacturing organisation, has initiated the $14 million construction of new facilities to …
Dermavant announces positive Phase III findings for psoriasis treatment tapinarof
February 19, 2021Medical Communications Dermavant Sciences, psoriasis
Dermavant Sciences has announced positive safety and efficacy results from a planned interim analysis of PSOARING 3, a long-term, open-label …
RedHill enters manufacturing deal with Cosmo for two key products
February 19, 2021Medical Communications RedHill Biopharma
RedHill Biopharma has announced agreements with Cosmo Pharmaceuticals to manufacture two of RedHill’s key products. Cosmo will manufacture Movantik, RedHill’s …
Onward and Biomunex agree deal to collaborate on cancer treatment
February 18, 2021Onward Therapeutics and Biomunex Pharmaceuticals have signed a co-development agreement of a bi-specific antibody for cancer patients.
Nektar and SFJ collaborate to develop experimental head and neck cancer drug
February 18, 2021Cancer, Nektar Therapeutics
Nektar Therapeutics has announced a financing and co-development collaboration with SFJ Pharmaceuticals to support the development of Bempegaldesleukin (BEMPEG), an investigational CD122-preferential …
MC2 Therapeutics grants Almirall European commercial rights for psoriasis cream Wynzora
February 18, 2021Almirall, MC2 Therapeutics, psoriasis
Biopharma company Almirall and MC2 Therapeutics, a pharmaceutical company focused on therapies for autoimmune and chronic inflammatory conditions, have announced …
Eli Lilly’s diabetes drug tirzepatide reduces blood glucose and weight in Phase III trials
February 18, 2021Eli Lilly, diabetes
Eli Lilly’s tirzepatide led to significant haemoglobin A1C (HbA1C) and body weight reductions from baseline in adults with type 2 …
Pharmafile.com’s weekly COVID-19 news round-up
February 17, 2021Research and Development COVID-19, COVID-19 vaccine, Vaccine, World Health Organisation, covid-19 roundup
The past week has continued to see positive COVID-19 vaccine news; a WHO panel approved the Oxford-AstraZeneca vaccine for all …
J&J’s one-shot COVID-19 vaccine submitted to the EU
February 17, 2021Research and Development COVID, COVID Vaccine, COVID-19, Johnson & Johnson, Vaccine
Johnson & Johnson has applied to the EMA for marketing authorisation of their one-shot COVID-19 vaccine in Europe.
AstraZeneca and MSD’s Lynparza crosses superiority boundary for invasive disease-free survival
February 17, 2021Research and Development AstraZeneca, Cancer, MSD
The OlympiA Phase III trial for AstraZeneca and MSD’s cancer drug Lynparza will move to early primary analysis and reporting, …
Novartis and Gates Foundation join forces on sickle cell disease research
February 17, 2021Research and Development Novartis, sickle cell disease
Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation, under which the foundation will fund …
FDA approves Novartis’ heart failure drug Entresto
February 17, 2021Research and Development FDA, Novartis
The FDA has approved Novartis’ Entresto (sacubitril/valsartan) to reduce the risk of cardiovascular death and hospitalisation for heart failure in …
North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data
February 16, 2021Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine
North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …
South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines
February 16, 2021Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea
South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.
WHO approves two versions of AstraZeneca’s COVID-19 vaccine
February 16, 2021Manufacturing and Production AstraZeneca, COVID-19, WHO
The WHO has greenlighted two versions of the Oxford-AstraZeneca COVID-19 vaccine for emergency use, granting them authorisation to be rolled …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
